Polyneuropathy
MONDO:0001824A disease or disorder affecting more than one nerve.
Also known as: polyneuropathy
137 clinical trials for this condition and its sub-types, 32 tagged with Polyneuropathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Polyneuropathy
-
Polyradiculoneuropathy 1 trial · 65 incl. sub-types
4 sub-types
-
Demyelinating polyneuropathy 2 trials · 63 incl. sub-types
2 sub-types
-
Chronic polyneuropathy 0 trials · 63 incl. sub-types
3 sub-types
-
Critical illness polyneuropathy 39 trials
-
Polyneuritis 3 trials
-
Toxic polyneuropathy 1 trial · 3 incl. sub-types
3 sub-types
- Polyneuropathy due to drug 2 trials
- Alcoholic polyneuropathy 0 trials
- Chronic toxic polyneuropathy 0 trials
-
Paraneoplastic polyneuropathy 0 trials
Most studied deeper sub-types
-
A cuff that squeezes the leg might save muscle in ICU patients
Disease control Not yet recruitingThis trial tests a rehabilitation technique called blood flow restriction training (BFRT) in adults on ventilators who develop ICU-acquired weakness, a condition of severe muscle loss. BFRT uses an inflatable cuff on the upper leg to partially restrict blood flow during low-inten…
Sponsor: Affiliated Hospital of Jining Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThis study tests the long-term safety and tolerability of acoramidis, an oral medication that stabilizes the transthyretin protein, in people newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition that can lead to heart failure. Participants who complete…
Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Experimental drug aims to tame rare nerve disorder
Disease control Not yet recruitingThis trial tests a drug called obinutuzumab β in people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a condition where the immune system attacks nerves, causing weakness and numbness. Participants receive two intravenous infusions of the drug and are mon…
Phase 1/2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for teens with rare nerve disease: drug trial launches
Disease control Not yet recruitingThis study tests a new medicine called empasiprubart in teenagers aged 12 to 17 who have a rare nerve disease called CIDP. The goal is to find the right dose and see if the drug is safe and helps control the disease. Participants will receive the drug for about 27 months and be f…
Phase 2/3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy aims to rebuild strength in older ICU patients
Disease control Not yet recruitingThis study tests a combination of high-protein supplements, mobility-based physical therapy, and neuromuscular electric stimulation in older adults (60+) who have been in the ICU for at least two weeks and now have muscle weakness. The goal is to see if this approach can improve …
Early phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Engineered immune cells take aim at multiple sclerosis and myasthenia gravis
Disease control Not yet recruitingThis early-phase trial will test a new treatment called QT-019C in up to 15 adults with relapsed or refractory neurological autoimmune diseases, including multiple sclerosis, neuromyelitis optica, and myasthenia gravis. The treatment uses donor-derived CAR T-cells that target two…
Early phase 1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New cell injection aims to tame Hard-to-Treat autoimmune nerve disorders
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called HY001N in 15 adults with relapsed or treatment-resistant autoimmune neurological diseases like neuromyelitis optica. The main goal is to check safety and side effects, while also looking for signs of improvement in disability…
Early phase 1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Ultrasound breakthrough could predict ICU paralysis days in advance
Diagnosis Not yet recruitingThis study explores whether a painless ultrasound technique, called shear wave elastography, can detect early signs of muscle weakness in critically ill patients on breathing machines. About 98 adults will have their nerves scanned on days 1, 4, and 7 in the ICU. The goal is to s…
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New needle technique could pinpoint painful nerves more accurately
Diagnosis Not yet recruitingThis study tests a new way to inject numbing medicine directly into a specific nerve root to find out which nerve is causing back and leg pain. The goal is to see if this method is safer and more accurate than current techniques. About 80 adults with sciatica who are scheduled fo…
Sponsor: Xi'an Honghui Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New exercise method aims to help ICU patients sit up faster
Symptom relief Not yet recruitingThis study tests whether a specific type of exercise, called proprioceptive neuromuscular facilitation (PNF), can improve trunk control in ICU patients who have developed muscle weakness. About 58 adults who have been in the ICU for at least 48 hours will be randomly assigned to …
Sponsor: Universidade Federal do Rio de Janeiro • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Exercise may ease Chemo's nerve pain, new study hopes to prove
Symptom relief Not yet recruitingThis study looks at whether exercise can lessen nerve damage caused by certain chemotherapy drugs. About 140 people with colorectal or gynecologic cancer will either exercise or receive usual care. Researchers will measure nerve function, blood markers, and quality of life to see…
Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
A muscle protein may signal nerve damage in diabetes — study puts it to the test
Knowledge-focused Not yet recruitingThis study investigates whether blood levels of irisin, a protein linked to glucose metabolism and nerve protection, differ in people with type 2 diabetes who have diabetic polyneuropathy (nerve damage) compared to those without it and healthy controls. Researchers will measure i…
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could your age change how a nerve test reads your nerves?
Knowledge-focused Not yet recruitingThis study looks at whether a person's age influences the accuracy of a nerve test called the sural-to-radial amplitude ratio (SRAR) in telling apart two types of peripheral neuropathy: length-dependent and non-length-dependent. Researchers will review medical records from about …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Ultrasound and blood markers may unlock personalized treatment for rare nerve disease
Knowledge-focused Not yet recruitingThis study investigates whether nerve ultrasound patterns and biomarkers in blood and spinal fluid can predict how people with chronic inflammatory demyelinating polyneuropathy (CIDP) respond to treatment. Researchers will follow 30 adults with CIDP, including newly diagnosed and…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Blood test may predict chemo nerve damage before it starts
Knowledge-focused Not yet recruitingThis study aims to find blood markers that can predict which cancer patients will develop chronic nerve pain from chemotherapy. Researchers will collect blood samples and perform neurological exams on 192 patients over 6 months. The goal is to use this information to personalize …
Sponsor: Centre Hospitalier de Bligny • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Massive Real-World study to track brain and nerve autoimmune disorders
Knowledge-focused Not yet recruitingThis study will follow 1,550 adults with various neurological autoimmune diseases—like multiple sclerosis, myasthenia gravis, and autoimmune encephalitis—to see how these conditions progress and respond to treatments in everyday medical practice. Researchers will measure disabili…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to uncover the Real-Life impact of nerve diseases
Knowledge-focused Not yet recruitingThis study looks at how two types of peripheral neuropathy—hereditary and inflammatory—affect daily life and well-being. Researchers will ask 60 adults to fill out questionnaires about their functioning, independence, and quality of life. No treatments are given; the goal is to b…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC